The table below shows LEMAITRE VASCULAR INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$249.60M
$219.86M
$193.48M
$161.65M
$154.42M
$129.37M
Cost of revenue
$71.06M
$68.96M
$66.44M
$56.76M
$53.04M
$44.75M
Gross profit
$178.54M
$150.90M
$127.05M
$104.90M
$101.38M
$84.62M
R&D
$14.14M
$15.65M
$16.97M
$13.29M
$11.80M
$10.10M
LMAT annual revenue (10-K history)
LEMAITRE VASCULAR INC reported annual revenue of $249.60M for fiscal year 2025. That is up 13.5% from $219.86M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $89.15M (FY 2016) to $249.60M. Figures come from the company's audited annual reports as filed with the SEC.